Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lentizol 25mg modified-release capsules
0403010B0BDAAAA
|
Lentizol | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Lentizol 50mg modified-release capsules
0403010B0BDABAB
|
Lentizol | Amitriptyline hydrochloride | Central Nervous System | No data available |
|
Letybo 50unit powder for solution for injection vials
0409030B0BHAAAD
|
Letybo | Botulinum toxin type A | Central Nervous System | No data available |
|
Leveraxo 10mg modified-release tablets
0407020ADBPABAF
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 20mg modified-release tablets
0407020ADBPACAG
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 30mg modified-release tablets
0407020ADBPADAR
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 40mg modified-release tablets
0407020ADBPAEAH
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 5mg modified-release tablets
0407020ADBPAAAK
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 60mg modified-release tablets
0407020ADBPAFAQ
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Leveraxo 80mg modified-release tablets
0407020ADBPAGAI
|
Leveraxo | Oxycodone hydrochloride | Central Nervous System | No data available |
|
Levetiracetam 1.5g/100ml infusion bags
0408010A0AAARAR
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 300mg/5ml oral liquid
0408010A0AAADAD
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 400mg/5ml oral liquid
0408010A0AAAEAE
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levetiracetam 500mg/100ml infusion bags
0408010A0AAAPAP
|
Levetiracetam | Levetiracetam | Central Nervous System | No data available |
|
Levodopa 100mg/5ml oral liquid
0409010I0AAAKAK
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 125mg/5ml oral suspension
0409010I0AAAJAJ
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 25mg/5ml oral suspension
0409010I0AAAMAM
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 33mg inhalation powder capsules with device
0409010I0AAANAN
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levodopa 500mg tablets
0409010I0AAAFAF
|
Levodopa | Levodopa | Central Nervous System | No data available |
|
Levomepromazine 10mg/5ml oral liquid
0402010K0AAAJAJ
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 12.5mg/5ml oral liquid
0402010K0AAAEAE
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 1mg capsules
0402010K0AAATAT
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 25mg/5ml oral liquid
0402010K0AAAFAF
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 3mg/5ml oral liquid
0402010K0AAAQAQ
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
|
Levomepromazine 4mg/5ml oral liquid
0402010K0AAAKAK
|
Levomepromazine maleate | Levomepromazine maleate | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.